Intellia Therapeutics
Nikhil Jain is a Senior Associate Scientist at Intellia Therapeutics, Inc., with a career spanning from 2016 to the present. Nikhil has held various positions in the biotechnology and pharmaceutical industries, including roles at CRISPR Therapeutics and Solid Biosciences, where expertise in developing assays for qPCR and droplet digital PCR platforms was applied to characterize residual DNA in AAV products. Nikhil's educational background includes a Master of Science in Pharmaceutics and Drug Delivery Systems from Northeastern University, as well as a Bachelor of Pharmacy from the University of Mumbai. Nikhil also gained experience in business as a Territory Business Manager at Abbott, where sales were increased by 8% in the assigned territories.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.